OxyPrem, the Zurich-based manufacturer of brain oxygen sensors for preterm-born children,
OxyPrem has raised €1.5M across 1 funding round from 1 investor, most recently a round in Aug 2024. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-08-30 | Other | €1.5M |
| Capital Cell |
| View deal → |
